Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Sep;100(9):829-35.
doi: 10.1684/bdc.2013.1781.

[Glutamate and malignant gliomas, from epilepsia to biological aggressiveness: therapeutic implications]

[Article in French]
Affiliations
Review

[Glutamate and malignant gliomas, from epilepsia to biological aggressiveness: therapeutic implications]

[Article in French]
Serge Blecic et al. Bull Cancer. 2013 Sep.

Abstract

In this review article, we describe the unrecognized roles of glutamate and glutamate receptors in malignant glioma biology. The neurotransmitter glutamate released from malignant glioma cells in the extracellular matrix is responsible for seizure induction and at higher concentration neuronal cell death. This neuronal cell death will create vacated place for tumor growth. Glutamate also stimulates the growth and the migration of glial tumor cells by means of the activation of glutamate receptors on glioma cells in a paracrine and autocrine manner. The multitude of effects of glutamate in glioma biology supports the rationale for pharmacological targeting of glutamate receptors and transporters in the adjuvant treatment of malignant gliomas in neurology and neuro-oncology. Using the website www.clinicaltrials.gov/ as a reference - a service developed by the National Library of Medicine for the National Health Institute in USA - we have evoked the few clinical trials completed and currently ongoing with therapies targeting the glutamate receptors.

Keywords: epilepsia; glutamate; invasion; malignant gliomas; migration; proliferation; sulfasalazine.

PubMed Disclaimer

MeSH terms

LinkOut - more resources